Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Abigail L. Toren"'
Autor:
Ann Hanna, Mellissa J. Nixon, M. Valeria Estrada, Violeta Sanchez, Quanhu Sheng, Susan R. Opalenik, Abigail L. Toren, Joshua Bauer, Phillip Owens, Frank M. Mason, Rebecca S. Cook, Melinda E. Sanders, Carlos L. Arteaga, Justin M. Balko
Publikováno v:
Breast Cancer Research, Vol 24, Iss 1, Pp 1-16 (2022)
Abstract Aim Deregulated signaling pathways are a hallmark feature of oncogenesis and driver of tumor progression. Dual specificity protein phosphatase 4 (DUSP4) is a critical negative regulator of the mitogen-activated protein kinase (MAPK) pathway
Externí odkaz:
https://doaj.org/article/6aa7b57ed41b4bac96b6712182f77f69
Autor:
Ann Hanna, Mellissa J. Nixon, M. Valeria Estrada, Violeta Sanchez, Quanhu Sheng, Susan R. Opalenik, Abigail L. Toren, Joshua Bauer, Phillip Owens, Frank M. Mason, Rebecca S. Cook, Melinda E. Sanders, Carlos L. Arteaga, Justin M. Balko
Publikováno v:
Breast cancer research : BCR. 24(1)
Aim Deregulated signaling pathways are a hallmark feature of oncogenesis and driver of tumor progression. Dual specificity protein phosphatase 4 (DUSP4) is a critical negative regulator of the mitogen-activated protein kinase (MAPK) pathway and is of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e86c8655c33a24b2d8196bc077eaadc2
https://pubmed.ncbi.nlm.nih.gov/35850776
https://pubmed.ncbi.nlm.nih.gov/35850776
Autor:
Margaret L. Axelrod, Wouter C. Meijers, Elles M. Screever, Juan Qin, Mary Grace Carroll, Xiaopeng Sun, Elie Tannous, Yueli Zhang, Ayaka Sugiura, Brandie C. Taylor, Ann Hanna, Shaoyi Zhang, Kaushik Amancherla, Warren Tai, Jordan J. Wright, Spencer C. Wei, Susan R. Opalenik, Abigail L. Toren, Jeffrey C. Rathmell, P. Brent Ferrell, Elizabeth J. Phillips, Simon Mallal, Douglas B. Johnson, James P. Allison, Javid J. Moslehi, Justin M. Balko
Publikováno v:
Nature, vol 611, iss 7937
Nature, 611(7937), 818-826. Nature Publishing Group
Nature, 611. Nature Publishing Group
Nature, 611(7937), 818-826. Nature Publishing Group
Nature, 611. Nature Publishing Group
Immune-related adverse events, particularly severe toxicities such as myocarditis, are major challenges to the utility of immune checkpoint inhibitors (ICIs) in anticancer therapy1. The pathogenesis of ICI-associated myocarditis (ICI-MC) is poorly un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48a9e654e239d5a2d33ccbae075f71de
https://doi.org/10.1038/s41586-022-05432-3
https://doi.org/10.1038/s41586-022-05432-3